Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (1): 129-132    DOI: 10.12891/ceog3148.2017
Experimental Research Previous articles | Next articles
The effect of leflunomide on the transplanted endometriosis lesions in SD rats
J.J. Yang1, 2, Y. Gao2, Y.H. Wang2, C.H. Wang2, L.D. Wang1, *(), B.B. Tao2, H.F. Guo2, S.G. Ding2, A.H. Wu2, G.R. Zhai2, X.M. Feng2
1 The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
2 Women and Infants Hospital of Zhengzhou, Zhengzhou, China
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objective: To investigate the effects of the leflunomide (LEF) on the size of the transplanted endometriosis (EMS) lesions and transforming growth factor (TGF) -β1gray level in SD rats. Materials and Methods: EMS was surgically induced in rats by autologous transplantation and the focal volume was also measured. The rats were divided into three groups: group A: normal SD rats, group B: rats irrigated by one ml·kg-1·d-1 saline for three weeks, and group C: rats irrigated by 35 mg·kg-1·d-1 LEF for three weeks. The rats were then sacrificed and measured their focal volume and TGF-β1 gray value with immunohistochemical method. Results: The sizes of the focal volume in group C were significantly reduced compared to the rats before feeding, and the volume in group C was smaller than group B after feeding and so was the TGF-β1. Conclusion: LEF could be a new therapeutic drug for EMS.
Key words:  Ectopic endometriosis model in rats      Endometriosis      Leflunomide      TGF-β1     
Published:  10 February 2017     
*Corresponding Author(s):  L.D. WANG     E-mail:  yjj_168@126.com

Cite this article: 

J.J. Yang, Y. Gao, Y.H. Wang, C.H. Wang, L.D. Wang, B.B. Tao, H.F. Guo, S.G. Ding, A.H. Wu, G.R. Zhai, X.M. Feng. The effect of leflunomide on the transplanted endometriosis lesions in SD rats. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 129-132.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3148.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I1/129

[1] H. Takagi, S. Yamada, J. Sakamoto, S. Fujita, T. Sasagawa. Hemostatic effects of kyukikyogaito in dienogest treatment[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 560-564.
[2] K. Chmaj-Wierzchowska, M. Wojciechowska, I. Parda, K. Plagens-Rotman, P. Rzymski, M. Wilczak. How do health problems affect the quality and everyday life of patients with endometriomas?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 571-575.
[3] X.J. Shi, L.B. Shi, S.Y. Zhang. Mechanistic study of vitamin C attenuation of endometriotic fibrosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 383-390.
[4] M. Ζafrakas, Κ. Κοtronis, P. Papasozomenou, P. Eskitzis, G. Grimbizis. Extracellular matrix metalloproteinases in the etiopathogenesis of endometriosis: a systematic review and critical appraisal[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 147-153.
[5] K.Y. Yun, S.Y. Hwang, H.J. Lee, S.C. Kim, J.K. Joo, D.S. Suh, K.H. Kim, K.S. Lee. The association of body mass index with incidence, stage and recurrence of endometriosis: case-control study in Korean women[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 53-56.
[6] Hue HJ, Kim SK, Choi JY, Suh DH, Kim KD, No JH, Lee JR, Jee BC, Kim YB, Jeon HW. Previous ovarian surgery increases the risk of tubal factor infertility[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 84-88.
[7] H.-H. Lee, M.-J. Mun, T.-H. Kim, Y.-S. Kim, W.-C. Jang, J.-Y. Hwang. Relationships between vitamin D receptor genetic polymorphisms and endometriosis in Korean women[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 876-880.
[8] A. Vitagliano, A. Andrisani, F. Dessole, G. Virdis, R. Cappadona, L. Marin, G. Capobianco, S. Dessole, G. Ambrosini. Rectovaginal endometriosis: head to head comparison between sonovaginography and magnetic resonance imaging[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 888-891.
[9] C. Hayashi, K. Matsumoto, K. Shinya, T. Nakajima, T. Nakao, A. Komatsu, F. Chishima, K. Kawana. The expression of angiotensin II receptors mRNA in granulosa-lutein cells in endometriosis patients who underwent ovarian surgery before in vitro fertilization[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 910-913.
[10] Songping Liu, Xin Tian, Hongyan Cui, Qiong Zhang, Keqin Hua. Feasibility of serum-free culture in isolating endometriotic stem cells[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 920-923.
[11] M. Paliga, S. Horák. Relationship between endometriosis and vitamin D status – a review[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 674-678.
[12] R. T. Ratner, A. Harris, J. Tsaltas, N. Goyal, M. Davies-Tuck, H. Najjar, O. Barel. An eight-year retrospective analysis of laparoscopic surgery for endometriosis, outcomes and complications in a large multicenter unit[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 699-703.
[13] Y.-S. Kim, J.-Y. Hwang, T.-H. Kim, E.-G. Lee, H.-H. Lee. Genome-wide association study of recurrent endometriosis related with ovarian cancer[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 553-559.
[14] K. Nakamura, K. Nakayama, T. Minamoto, T. Ishibashi, K. Sanuki, H. Yamashita, R. Ono, H. Sasamori, S. Razia, M.M. Hossain, S. Kamrunnahar, M. Ishikawa, S. Kyo. A novel retrograde approach for total laparoscopic hysterectomy in patients with severe adhesion in the cul-de-sac[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 565-569.
[15] H. Takagi, J. Sakamoto, T. Sasagawa. Long-term treatment of endometriosis with dienogest for up to five years[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 398-402.
No Suggested Reading articles found!